Terms: = Ovarian cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
45 results:
1. n-myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of ovarian cancer, in Its Association with Beta-Catenin.
Terada A; Tsuda N; Tasaki S; Park J; Nasu H; Tasaki K; Katsuda T; Nishio S; Yamaguchi T; Sanada S; Akiba J; Kuwano M; Ono M; Ushijima K
Kurume Med J; 2023 Nov; 69(1.2):39-46. PubMed ID: 37793886
[TBL] [Abstract] [Full Text] [Related]
2. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
[TBL] [Abstract] [Full Text] [Related]
3. Epithelial-to-Mesenchymal Transition Supports ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.
Ho GY; Kyran EL; Bedo J; Wakefield MJ; Ennis DP; Mirza HB; Vandenberg CJ; Lieschke E; Farrell A; Hadla A; Lim R; Dall G; Vince JE; Chua NK; Kondrashova O; Upstill-Goddard R; Bailey UM; Dowson S; Roxburgh P; Glasspool RM; Bryson G; Biankin AV; ; Cooke SL; Ratnayake G; McNally O; Traficante N; ; DeFazio A; Weroha SJ; Bowtell DD; McNeish IA; Papenfuss AT; Scott CL; Barker HE
Cancer Res; 2022 Dec; 82(23):4457-4473. PubMed ID: 36206301
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Poetsch AR; Jaschke N; Hofbauer LC; Göbel A; Rachner TD; Kuhlmann JD
Clin Chem Lab Med; 2022 Jan; 60(1):109-117. PubMed ID: 34687595
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of NDRG2 promotes the therapeutic effect of pazopanib on ovarian cancer.
Cui Y; Shen G; Ma L; Lv Q
J Recept Signal Transduct Res; 2021 Dec; 41(6):546-552. PubMed ID: 33050824
[TBL] [Abstract] [Full Text] [Related]
6. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
7. ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
[TBL] [Abstract] [Full Text] [Related]
8. Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer.
Li Y; Wang Q; Ning N; Tang F; Wang Y
J Ovarian Res; 2020 Jul; 13(1):77. PubMed ID: 32660514
[TBL] [Abstract] [Full Text] [Related]
9. NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.
Kang F; Wang Y; Luo Y; Zhang Y
J Ovarian Res; 2020 Apr; 13(1):48. PubMed ID: 32345304
[TBL] [Abstract] [Full Text] [Related]
10. ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.
Jung M; Gao J; Cheung L; Bongers A; Somers K; Clifton M; Ramsay EE; Russell AJ; Valli E; Gifford AJ; George J; Kennedy CJ; Wakefield MJ; Topp M; Ho GY; ; Scott CL; Bowtell DD; deFazio A; Norris MD; Haber M; Henderson MJ
Int J Cancer; 2020 Oct; 147(8):2225-2238. PubMed ID: 32277480
[TBL] [Abstract] [Full Text] [Related]
11. ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells.
Dausinas P; Pulakanti K; Rao S; Cole JM; Dahl R; Cowden Dahl KD
Gene; 2020 May; 738():144458. PubMed ID: 32061921
[TBL] [Abstract] [Full Text] [Related]
12. UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2.
Wang H; Su H; Tan Y
Cell Biol Int; 2020 Apr; 44(4):1028-1036. PubMed ID: 31903696
[TBL] [Abstract] [Full Text] [Related]
13. Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families.
Castéra L; Harter V; Muller E; Krieger S; Goardon N; Ricou A; Rousselin A; Paimparay G; Legros A; Bruet O; Quesnelle C; Domin F; San C; Brault B; Fouillet R; Abadie C; Béra O; Berthet P; ; Frébourg T; Vaur D
Genet Med; 2018 Dec; 20(12):1677-1686. PubMed ID: 29988077
[TBL] [Abstract] [Full Text] [Related]
14. Impact of coexistent adenomyosis on outcomes of patients with endometrioid endometrial cancer: a propensity score-matched analysis.
Aydin HA; Toptas T; Bozkurt S; Pestereli E; Simsek T
Tumori; 2018; 104(1):60-65. PubMed ID: 29192745
[TBL] [Abstract] [Full Text] [Related]
15. Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment Annual Report for 2009.
Saito T; Takahashi F; Katabuchi H;
J Obstet Gynaecol Res; 2017 Nov; 43(11):1667-1677. PubMed ID: 28892220
[TBL] [Abstract] [Full Text] [Related]
16. Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis.
Mo J; Wang L; Huang X; Lu B; Zou C; Wei L; Chu J; Eggers PK; Chen S; Raston CL; Wu J; Lim LY; Zhao W
Nanoscale; 2017 Sep; 9(35):13142-13152. PubMed ID: 28849826
[TBL] [Abstract] [Full Text] [Related]
17. Safety outcomes of female sterilization by salpingectomy and tubal occlusion.
Westberg J; Scott F; Creinin MD
Contraception; 2017 May; 95(5):505-508. PubMed ID: 28232128
[TBL] [Abstract] [Full Text] [Related]
18. A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated cancers.
Jung M; Russell AJ; Liu B; George J; Liu PY; Liu T; DeFazio A; Bowtell DD; Oberthuer A; London WB; Fletcher JI; Haber M; Norris MD; Henderson MJ
Cancer Res; 2017 Feb; 77(4):971-981. PubMed ID: 27923830
[TBL] [Abstract] [Full Text] [Related]
19. An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma.
Baratta MG; Schinzel AC; Zwang Y; Bandopadhayay P; Bowman-Colin C; Kutt J; Curtis J; Piao H; Wong LC; Kung AL; Beroukhim R; Bradner JE; Drapkin R; Hahn WC; Liu JF; Livingston DM
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):232-7. PubMed ID: 25535366
[TBL] [Abstract] [Full Text] [Related]
20. Biology of childhood germ cell tumours, focussing on the significance of microRNAs.
Murray MJ; Nicholson JC; Coleman N
Andrology; 2015 Jan; 3(1):129-39. PubMed ID: 25303610
[TBL] [Abstract] [Full Text] [Related]
[Next]